MRVI - Maravai Lifesciences Holdings  - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

MRVI is currently covered by 11 analysts with an average price target of $11.57. This is a potential upside of $3.9 (50.85%) from yesterday's end of day stock price of $7.67.

Maravai Lifesciences Holdings 's activity chart (see below) currently has 23 price targets and 56 ratings on display. The stock rating distribution of MRVI is 72.09% BUY and 27.91% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 46.14% with an average time for these price targets to be met of 49 days.

Highest price target for MRVI is $21, Lowest price target is $6, average price target is $11.57.

Most recent stock forecast was given by DANIEL ARIAS from STIFEL on 23-Feb-2024. First documented stock forecast 15-Dec-2020.

Currently out of the existing stock ratings of MRVI, 31 are a BUY (72.09%), 12 are a HOLD (27.91%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

10

$2.33 (30.38%)

11

2 months 3 days ago

2/7 (28.57%)

$1.64 (19.62%)

96

Buy

10

$2.33 (30.38%)

17

4 months 14 days ago

0/2 (0%)

$4.41 (78.89%)

Hold

7

$-0.67 (-8.74%)

8

5 months 17 days ago

7/8 (87.5%)

$2.3 (48.94%)

67

Buy

11

$3.33 (43.42%)

12

5 months 17 days ago

2/11 (18.18%)

$6.3 (134.04%)

105

Buy

10

$2.33 (30.38%)

17

5 months 18 days ago

0/4 (0%)

$5.3 (112.77%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRVI (Maravai Lifesciences Holdings ) average time for price targets to be met?

On average it took 49 days on average for the stock forecasts to be realized with a an average price target met ratio 46.14

Which analyst has the current highest performing score on MRVI (Maravai Lifesciences Holdings ) with a proven track record?

TEJAS SAVANT

Which analyst has the most public recommendations on MRVI (Maravai Lifesciences Holdings )?

Tejas Savant works at MORGAN STANLEY and has 15 price targets and 8 ratings on MRVI

Which analyst is the currently most bullish on MRVI (Maravai Lifesciences Holdings )?

Erin Wright with highest potential upside - $39.7

Which analyst is the currently most reserved on MRVI (Maravai Lifesciences Holdings )?

John Sourbeer with lowest potential downside - -$1.67

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?